We serve Dimethoxydimethylsilane CAS:1112-39-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Dimethoxydimethylsilane
CAS.NO:1112-39-6
Synonyms:Silane, dimethoxydimethyl-; Dimethyldimethoxysilane;
DiMethoxydiMethylsilane;
Molecular Formula:C4H12O2Si
Molecular Weight:120.22200
Physical and Chemical Properties:
Density:0.88;
Melting point:-80oC;
Boiling point:81.4oC;
Flash point:-8oC;
Index of Refraction:1.3708;
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥98.0%
Packing:170 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is used for the synthesis of chemical intermediates.
It is used as an additive for the production of silicone resins.
It is used for hydrophobization of surfaces, like glass, pigments etc.
Contact us for information like Dimethoxydimethylsilane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,DiMethoxydiMethylsilane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,DiMethoxydiMethylsilane Use and application,Dimethyldimethoxysilane technical grade,usp/ep/jp grade.
Related News: ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.2-Bromo-4-fluoroaniline manufacturer Who is at risk of infection? People of all ages can be infected with the virus, but older people and those with pre-existing medical conditions are especially vulnerable to severe complications.4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene supplier Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.Trichloro(3,3,3-trifluoropropyl)silane vendor A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.
